Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.
People listings are free. Information must be submitted at least 11 days before the Monday issue in which it is to appear. Publication of information might be delayed due to space limitations. To submit information and photos online go to www.ibj.com and use the People submissions form. Photos may be sent as jpegs, 300 dpi […]
Eli Lilly and Co.’s Alzheimer’s drug slowed cognitive decline 34 percent in patients with mild forms of the disease, according to an analysis of Lilly’s clinical trial data released Monday. Lilly’s share price jumped more than 5 percent on the news.
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
A Colorado couple who both graduated from DePauw University have donated $25 million to the private liberal arts college to build a new dining hall and to endow need-based scholarships.
R. David and Suzanne Hoover, both 1967 graduates of DePauw University, will contribute $9 million to need-based scholarships, with the rest providing the lead gift for Hoover Hall.
The $91 million water and sewer deal is expected to improve water distribution between northeast and northwest suburbs.
Indianapolis city-county councilors hope expanding the downtown TIF district will mean more jobs for their constituents. Developers, city contractors and other firms benefiting from the expanded economic-development zone must try to ensure that 40 percent of their work force comes from within the expanded TIF area.
More than 100 local groups are joining forces to rehabilitate neglected rivers and streams in Marion County in the hope of sparking redevelopment.
WALL: One of the big changes coming out of the 2010 health reform law is a push for health care providers to provide care more based on value, a little less based on volume of services. One concept toward that goal is this accountable care organization concept. It’s similar in many ways to health maintenance […]
Indianapolis Business Journal convened a panel of experts at its Health Care & Benefits Power Breakfast on Sept. 28 to talk about industry issues including Medicaid, on-site health clinics and narrow networks. Panelists included Robert J. Brody, president and CEO of Franciscan St. Francis Health; Michael N. Heaton, partner, Katz Sapper & Miller; Dr. Gregory N. Larkin, commissioner, Indiana State Department of Health; Vicki F. Perry, president, CEO, Advantage Health Solutions Inc.; Dr. Ram Yeleti, president, Community Physician Network. The following is the unedited transcript of the discussion.
Joyce Irwin has been named CEO of Community Health Network Foundation, the charitable arm of the Indianapolis-based Community Health Network hospital system. On Oct. 22, Irwin will replace Dr. Jeffrey Boester, who has served as interim CEO since June, following the departure of Michele Dole. Irwin was most recently national director of state government affairs, regulatory and public policy at Roche Diagnostics Corp. in Indianapolis. Before Roche, Irwin worked as a consultant on corporate public policy for Eli Lilly and Co. She holds bachelor's and master's degrees in education from Indiana University.
AIT Laboratories has named Paula Conroy its chief financial officer. Conroy most recently operated her own consulting business specializing in CFO services for privately held companies. Conroy previously worked at the U.S. Securites & Exchange Commission and Ernst & Young LLP. She holds both a bachelor’s in management and an MBA from Purdue University and is a certified public accountant.
Dr. Sarah Ali, an oncologist and hematologist, has joined Franciscan Physician Network Oncology & Hematology Specialists on the south side. Ali earned her medical degree at St. George’s University School of Medicine in Grenada, West Indies, and completed a hematology-oncology fellowship at Michigan State University.
Sean Fallon has been named chief technology officer for CNO Financial Group Inc. He most recently worked at Lincoln Financial Group, where he served as vice president for application development in its group protection division. Fallon holds a bachelor’s degree in business and finance from the University of Wisconsin at Madison and a master’s in finance from the University of Wisconsin at Milwaukee.
The Fishers-based Behavior Analysis Center for Autism hired psychologist Genae Hall as its new research director and consultant. She currently serves as the co-director of Behavior Analysis and Intervention Services. A native of California, Hall holds a bachelor’s degree in psychology from the University of California at Santa Barbara, a master’s in psychology from Western Michigan University, and a doctorate in psychology from West Virginia University.
The nightmare that culminated with the Plainfield-based company’s recent Chapter 11 bankruptcy filing began in the depths of the financial crisis, when the company’s lender yanked its more-than-$10-million line of credit.
CityWay’s design does a lot of things well. Its site plan is woven into the Indy grid, providing active street edges.
The ailing Indianapolis Symphony Orchestra intends to step up annual donations 40 percent. But many longtime donors feel conflicted about future contributions as they await word on whether the ISO will scale back to part time.
Federal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing over the last 20 years, according to a new report by consumer advocacy group Public Citizen.
A Cicero-based developer has won city approval to build a $15.7 million senior health care center at 16th Street and Arlington Avenue on Indianapolis’ east side. The city’s Metropolitan Development Commission gave its blessing Sept. 19 after accepting an offer from Mainstreet Property Group LLC to purchase the property for $912,500. The city bought the nine-acre parcel from the federal government for $1 in September 2004. It had been used by Raytheon Technical Services Co. LLC. Nearly half of the project’s cost could be financed by $7.4 million in city-issued bonds. Mainstreet’s plans for the center call for 70 skilled-nursing and 30 assisted-living beds. The facility is expected to create up to 150 jobs, Mainstreet officials said. The project would be Mainstreet’s first newly constructed facility in Marion County. In 2006, it purchased out of bankruptcy the Highland Health and Living Center in Indianapolis at 2926 N. Capitol Ave. The company owns or co-owns 13 senior health care centers in Indiana, Illinois and Ohio, and has six more under development. It plans to break ground on up to 12 centers by the end of the year, including a $13.3 million facility in Westfield.
A European Union committee has endorsed the use of Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate, according to the Associated Press. The EU’s Committee for Medicinal Products for Human Use recommended approval of Cialis for benign prostatic hyperplasia. The condition often comes with such symptoms as the need to urinate urgently and frequently. The European Commission usually decides on the committee's opinion within a month or two, Lilly said Friday. The Commission is not required to adopt the committee recommendation, but it usually does. The U.S. Food and Drug Administration approved Cialis last fall for the treatment of symptoms of an enlarged prostate. Regulators also have approved the use in Canada, Mexico and Brazil, among other countries. Cialis brought in $1.88 billion last year. Its patents will last until 2017.
Indiana’s adult obesity rate is predicted to climb from 25 percent now to 56 percent by 2030, according to new projections released by the Trust for America’s Health and the Robert Wood Johnson Foundation. That shocking increase would move Indiana from the 38th-most-obese state now to the 26th-most-obese state. Mississippi is predicted to lead the nation in obesity in 2030, as it does now. And even Colorado, which has the least obese population—with only 21 percent obese—is predicted to have 45 percent of its adults obese in 2030. The report, titled "F as in Fat,” was released on Sept. 18. “This study shows us two futures for America’s health,” said Dr. Risa Lavizzo-Mourey CEO of the New Jersey-based Robert Wood Johnson Foundation. "At every level of government, we must pursue policies that preserve health, prevent disease and reduce health care costs. Nothing less is acceptable.”
Dr. Kristina Whitesell, a pediatrician, has established a practice with Franciscan Physician Network Heartland Crossing Pediatrics in Camby. Whitesell earned her medical degree at Washington University School of Medicine in St. Louis and also earned a bachelor’s degree in biochemistry from Gustavus Adolphus College in Minnesota.
Indianapolis law firm Hall, Render, Killian, Heath & Lyman has hired attorney Janelle McIntyre as part of its Indianapolis litigation group. McIntyre completed her undergraduate studies at Indiana University and earned her law degree at IU McKinney School of Law.
After nearly 30 years as an attorney at Indianapolis law firm Riley, Bennett & Egloff, Mary Reeder has accepted a position as in-house general counsel at Reid Hospital & Health Care Services in Richmond.
Victor Vinci has joined Bloomington-based Cook Pharmica as chief scientific officer. Prior to joining Cook, Vinci worked many years at Eli Lilly and Co. in Indianapolis. He also spent six years at Merck & Co. Inc. He holds a master’s degree and a doctorate in microbiology from The Ohio State University. He also holds a bachelor’s degree in chemistry and microbiology from Bowling Green State University.
You know things are bad in the fiercely competitive pharma industry when drugmakers start turning to each other for help. But that’s exactly what happened last week when 10 major drug companies—including Eli Lilly and Co.—joined forces to cut costs out of clinical trials.
Novo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.
